Characteristics of ADHD symptom response/remission in a clinical trial of methylphenidate extended release

Authors

Margaret Weiss, Cambridge Health Alliance
Ann Childress, Center for Psychiatry and Behavioral Medicine, Inc.
Earl Nordbrock, Rhodes Pharmaceuticals L.P.
Akwete L. Adjei, Rhodes Pharmaceuticals L.P.
Robert J. Kupper, Rhodes Pharmaceuticals L.P.
Greg Mattingly, Washington University School of Medicine in St. Louis

Journal

Journal of Clinical Medicine

Publication Date

2019

Volume

8

Issue

4

Inclusive Pages

461

Document Type

Open Access Publication

DOI

10.3390/jcm8040461

Rights and Permissions

Weiss M, Childress A, Nordbrock E, Adjei AL, Kupper RJ, Mattingly G. Characteristics of ADHD Symptom Response/Remission in a Clinical Trial of Methylphenidate Extended Release. Journal of Clinical Medicine. 2019; 8(4):461. DOI:10.3390/jcm8040461.

Recommended Citation

Weiss, Margaret; Childress, Ann; Nordbrock, Earl; Adjei, Akwete L.; Kupper, Robert J.; and Mattingly, Greg, "Characteristics of ADHD symptom response/remission in a clinical trial of methylphenidate extended release." Journal of Clinical Medicine. 8, 4. 461. (2019).
https://digitalcommons.wustl.edu/open_access_pubs/7814